PMHNP Scope of Practice for General Psychiatry in Illinois

If you’re a psychiatrist or psychiatric NP wondering whether you can legally prescribe ADHD meds, benzos, or other controlled substances through telehealth — you’re asking the right question at the right time.

The short answer: Yes, you can prescribe controlled substances via telehealth in 2026 — but the rules are changing, and what’s allowed depends on both federal DEA regulations and your state’s specific laws.

Here’s what you actually need to know to practice compliantly (and profitably) right now.

The Current State: DEA Extension Through End of 2026

As of January 2026, federal telehealth flexibilities for controlled substance prescribing have been extended through December 31, 2026. This is the fourth extension since the COVID public health emergency ended, and it means you can continue prescribing Schedule II–V medications via telemedicine without requiring an initial in-person exam.

What this means practically:

• You can evaluate a new patient via video and prescribe Adderall for ADHD, Xanax for anxiety, or buprenorphine for opioid use disorder without ever seeing them in person
• This applies to psychiatrists, PMHNPs, and all DEA-registered prescribers
• The encounter must use real-time, two-way audio-visual communication (video call, not just phone for most controlled substances)
• You still need to meet the standard of care — thorough evaluation, proper documentation, legitimate medical purpose

The catch: This is temporary. The DEA is finalizing permanent rules that will change the landscape significantly, likely before the end of 2026.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What’s Coming: DEA’s Permanent Telehealth Rules

In January 2025, the DEA proposed three new rules to replace the temporary COVID extensions. Here’s what psychiatrists need to know:

1. Special Telemedicine Registration for Schedule II Prescribing

The DEA is creating a ‘Special Telemedicine Prescriber Registration’ that would allow qualified providers to prescribe controlled substances to new patients via telehealth without any in-person visit requirement.

For psychiatrists, this is significant: Board-certified psychiatrists are explicitly included in the list of specialties eligible to obtain this special registration for Schedule II substances (stimulants, etc.). This means if you’re board-certified in psychiatry, you could register to prescribe Adderall, Ritalin, and other Schedule II medications entirely via telehealth for ADHD and other psychiatric conditions.

For Schedule III–V medications, any qualified prescriber could obtain the special registration.

What you’ll likely need:

• Apply for and obtain the special DEA telemedicine registration
• Meet qualifications (board certification for Schedule II authority)
• Potentially report telehealth controlled substance activity annually
• Follow additional safety protocols the DEA establishes

2. Buprenorphine Gets Special Treatment

For providers treating opioid use disorder, the DEA’s proposed rule allows up to 6 months of buprenorphine treatment via telehealth (including audio-only for access) before requiring an in-person evaluation. After 180 days, you’d need to see the patient in person or refer them for an in-person evaluation to continue treatment.

This recognizes that addiction treatment via telehealth has been highly effective and shouldn’t face the same barriers as other controlled substance prescribing.

3. Platform Registration Requirements

For the first time, online telehealth platforms would need to register with the DEA. This is designed to hold platforms accountable if they facilitate inappropriate prescribing (a response to well-publicized cases of telehealth startups overprescribing stimulants).

A national PDMP (Prescription Drug Monitoring Program) would also be created to track controlled prescriptions across state lines.

Timeline: These are proposed rules currently in public comment. Final implementation is expected sometime in 2026. Until then, the extension allows current practices to continue.

State Rules: Where It Gets Complicated

Federal law sets the floor, but states can impose stricter requirements. Here’s what you need to know for the six largest telehealth markets:

California: Straightforward with PDMP Requirements

Bottom line: No state-level restrictions on telehealth controlled substance prescribing beyond federal law.

Key requirements:

• Must have California medical license
• Mandatory CURES PDMP check before prescribing Schedule II–IV controlled substances for the first time, then every 4 months during ongoing treatment
• 100% e-prescribing required (since 2022)
• Standard of care via video is sufficient — no in-person requirement

For PMHNPs: California is transitioning to full practice authority. By 2026, experienced NPs (with 3+ years in supervised settings) can practice and prescribe independently, including controlled substances.

Texas: MD-Friendly, NP-Restrictive

Bottom line: Psychiatrists can prescribe controlled substances via telehealth. NPs face significant limitations.

Key requirements:

• Real-time audio-video required for initial evaluation
• Texas PMP check mandatory before prescribing opioids, benzos, barbiturates, or carisoprodol
• Critical limitation for NPs: PMHNPs and PAs cannot prescribe Schedule II controlled substances (Adderall, Ritalin) in outpatient settings — only in hospitals or hospice
• Chronic pain management via telehealth prohibited without in-person exam (doesn’t typically affect psychiatry)

What this means: If you’re operating in Texas and treating ADHD patients, you need an MD or DO to write stimulant prescriptions. NPs can handle Schedule III–V (many anxiety meds, some sleep aids) but not Schedule II.

Florida: Psychiatric Exception Makes It Work

Bottom line: Florida explicitly allows Schedule II prescribing via telehealth for psychiatric treatment.

Key requirements:

• Must be Florida-licensed OR register as out-of-state telehealth provider
• Schedule II controlled substances cannot be prescribed via telehealth EXCEPT for: psychiatric disorder treatment, inpatient care, hospice, or nursing home residents
• Schedules III–V allowed via telehealth with standard care
• Mandatory E-FORCSE PDMP check before prescribing any controlled substance to patients ≥16 years old
• E-prescribing required

What this means: As a psychiatrist prescribing Adderall for ADHD (a psychiatric condition), you’re covered under the psychiatric exception. Document the psychiatric diagnosis clearly. Out-of-state providers can register to practice telehealth in Florida without full licensure, but the same prescribing rules apply.

For PMHNPs: Florida requires physician collaboration — no independent practice for psychiatric NPs. You’ll need a supervising psychiatrist on record.

New York: Liberal But With Strict Monitoring

Bottom line: No state restrictions on telehealth controlled substance prescribing. Very strict PDMP requirements.

Key requirements:

• Must have New York medical license
• Mandatory I-STOP PMP check before EVERY Schedule II, III, or IV prescription (among the strictest in the nation)
• 100% e-prescribing required for all prescriptions (since 2016)
• Video evaluation sufficient to establish patient relationship

For PMHNPs: Experienced NPs (>3,600 clinical hours) can practice fully independently, including prescribing all controlled substances. New NPs need a collaborative agreement until they hit the hour threshold.

Pennsylvania: Standard Care, Collaborative Requirements

Bottom line: No specific telehealth prescribing restrictions. State relies on professional standard of care.

Key requirements:

• Pennsylvania medical license required
• PDMP check mandatory before prescribing opioids or benzodiazepines (and recommended for all controlled substances)
• E-prescribing required for controlled substances (since 2019)
• No formal telehealth statute yet — follow general medical practice standards

For PMHNPs: Must have collaborative agreement with at least two physicians for prescriptive authority. Can prescribe Schedule II for up to 30 days, Schedule III–IV for up to 90 days, under delegation.

Illinois: Full Practice Available, Some Limitations

Bottom line: No Illinois-specific telehealth controlled substance ban. Standard of care applies.

Key requirements:

• Illinois medical license required
• Mandatory ILPMP check before prescribing opioids
• E-prescribing required for all controlled substances (since 2023)
• Standard telehealth evaluation sufficient

For PMHNPs: Can obtain Full Practice Authority (FPA) license after 4,000 hours and additional training. However, even with FPA, must have physician consultation for continuous Schedule II or benzodiazepine prescribing (30-day limit without consultation). This may affect ADHD medication management for NPs.

The Economics: Why This Matters for Your Practice

Understanding these regulations isn’t just about compliance — it’s about building a sustainable telehealth practice that can actually generate patient volume and income.

The reality of DIY patient acquisition:Most providers who try to build a telehealth practice through traditional marketing channels face:

• $200–500+ cost per booked patient when you factor in Google Ads ($15–40 per click, low conversion), agency fees, staff time qualifying leads, no-shows from cold leads
• 6–12 months before SEO generates meaningful patient flow
• $3,000–5,000/month in marketing spend with uncertain ROI
• Directory listing fees (Psychology Today, Zocdoc) plus monthly subscriptions — and you’re competing with hundreds of other providers on the same page

The platform alternative:Networks like Klarity Health use a fundamentally different model:

• Pay-per-appointment instead of upfront marketing spend
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

Why this matters with prescribing regulations: If you’re in a state like Texas where NPs can’t prescribe Schedule II, you need to either be an MD/DO or have an MD partner through your platform. If you’re in Florida, you need to ensure your psychiatric diagnosis is properly documented. A platform that understands these nuances and handles compliance infrastructure removes a massive burden.

Instead of gambling $5,000/month on marketing that might not work, you pay only when a qualified patient books with you. That’s guaranteed ROI.

Compliance Checklist: What You Must Do Now

Regardless of where you practice, here’s your compliance baseline:

Federal Requirements (All States)

✅ DEA registration in each state where you’re treating patients✅ Complete 8-hour MAT Act training on substance use disorder treatment (required for DEA registration/renewal since 2023)✅ Use secure, HIPAA-compliant video platform for telehealth✅ Document thorough evaluation justifying controlled substance prescription✅ E-prescribe controlled substances (required in most states, best practice everywhere)✅ Check patient’s controlled substance history via PDMP (mandatory in most states)✅ Follow standard of care — same thoroughness as in-person evaluation

State-Specific Add-Ons

✅ California: Check CURES PDMP before first Rx and every 4 months✅ Texas: Check Texas PMP for opioids/benzos; ensure NPs aren’t prescribing Schedule II outpatient✅ Florida: Verify psychiatric indication for Schedule II telehealth prescriptions; check E-FORCSE PDMP✅ New York: Check I-STOP PMP before EVERY controlled substance prescription✅ Pennsylvania: Check PA PMP before opioid/benzo prescriptions✅ Illinois: Check ILPMP before opioid prescriptions

If You’re a PMHNP

✅ Verify your state’s scope of practice and supervision requirements✅ If in restricted state (TX, FL), establish required physician collaboration✅ If in full practice state, obtain appropriate independent practice certification✅ Know your prescriptive authority limits (especially for Schedule II in states like Illinois)

Common Questions Psychiatrists Actually Ask

‘Can I prescribe Adderall via telehealth to a new patient I’ve never met in person?’

Through end of 2026: Yes, under the federal DEA extension, as long as you conduct a proper video evaluation, document it thoroughly, and follow state law (which generally allows it, with Florida requiring documentation of psychiatric indication).

After permanent rules: Likely yes, IF you obtain the special DEA telemedicine registration (psychiatrists are on the eligible specialty list). Without it, you may need an in-person exam or referral.

‘Do I need to see the patient in person eventually?’

Currently: No federal requirement. Some providers choose to see patients in person periodically for clinical reasons (to do physical exam, build rapport), but it’s not legally mandated under current DEA extension.

Under proposed rules: Depends on registration type and medication. Buprenorphine would require in-person after 6 months. For other meds with special registration, potentially no in-person requirement at all.

‘What if my patient moves to another state?’

You need a medical license and DEA registration in the new state to continue prescribing. This is where multi-state licensing (IMLC for physicians) helps. Many telehealth providers maintain licenses in multiple states for this reason.

‘Can I do phone-only visits for controlled substance prescribing?’

Generally no for most controlled substances. Federal guidance requires real-time audio-visual (video) for the telemedicine exception to apply. The exception is buprenorphine for OUD, where audio-only is explicitly allowed under the proposed rules.

For non-controlled psych meds, audio-only may be acceptable depending on state law and clinical situation, but for controlled substances, use video.

‘What about collaborative practice agreements for NPs across state lines?’

The supervising physician must be licensed in the state where the NP is practicing (i.e., where the patient is located). A Texas NP treating Texas patients via telehealth needs a Texas-licensed supervising physician, even if the NP is physically in another state during the video call.

‘How do I check multiple state PDMPs for patients who travel?’

Most states now participate in interstate PDMP data sharing (PMP Interconnect). When you query your state’s PDMP, it often shows controlled substance history from other participating states automatically. Some states require you to check each state’s PDMP individually if the patient has lived in multiple states — check your state’s specific PDMP rules.

The Smart Move: Focus on Patients, Not Compliance Headaches

Here’s the reality: these regulations are complex, changing, and vary by state. While it’s crucial to understand them, spending your time navigating 50 different state laws, managing multiple DEA registrations, setting up PDMP accounts, and figuring out telehealth platform compliance isn’t why you went to medical school.

What works: Joining a platform that:

• Already handles multi-state licensing requirements
• Has compliance infrastructure built in (PDMP checks, e-prescribing, documentation standards)
• Pre-qualifies patients so you’re not wasting time on intake calls with people who aren’t a fit
• Manages the entire billing and insurance process
• Matches you with patients who need your specific expertise

What doesn’t work: Trying to build all this yourself while also seeing patients, managing marketing, handling billing, staying on top of regulatory changes, and maintaining work-life balance.

The providers who thrive in telehealth are the ones who recognize that patient acquisition and compliance infrastructure are specialized skills — and it makes more financial sense to pay a per-appointment fee to a platform that delivers qualified patients than to build and maintain all that infrastructure yourself.

Your Next Step

Whether you’re a psychiatrist looking to add telehealth to your existing practice, a PMHNP wanting to practice independently (in states that allow it), or a provider considering going fully remote — understanding the controlled substance prescribing rules is your foundation.

Right now (through 2026): You have maximum flexibility. Take advantage of it to build telehealth into your practice.

Looking ahead: Plan for the new DEA registration requirements. If you’re a board-certified psychiatrist, the special telemedicine registration will likely be worth obtaining to maintain your ability to treat ADHD and other conditions requiring Schedule II medications entirely via telehealth.

Most importantly: Focus on what you do best — evaluating and treating patients — and let a platform like Klarity Health handle the patient acquisition, compliance infrastructure, and administrative burden.

Ready to see what telehealth psychiatry can do for your practice and income? Explore joining Klarity Health’s provider network and get matched with pre-qualified patients who need your expertise — without the marketing spend or compliance headaches.

Frequently Asked Questions

Q: Is telehealth prescribing of controlled substances legal after the COVID emergency ended?

A: Yes. The DEA has extended the COVID-era telehealth flexibilities through December 31, 2026. You can prescribe Schedule II–V controlled substances via telehealth without a prior in-person exam during this period, as long as you conduct a proper video evaluation and follow state law.

Q: What happens in 2027 when the extension expires?

A: The DEA is finalizing permanent rules that will likely require providers to obtain a special telemedicine registration to continue prescribing controlled substances (especially Schedule II) via telehealth without in-person exams. Psychiatrists are explicitly included as eligible for this registration.

Q: Can psychiatric nurse practitioners prescribe controlled substances via telehealth?

A: It depends on the state. In full practice states like New York (for experienced NPs) and California (by 2026), yes — PMHNPs can prescribe controlled substances independently via telehealth. In restricted states like Texas, NPs cannot prescribe Schedule II outpatient at all, and in Florida, NPs need physician supervision for all prescribing.

Q: Do I need separate DEA registrations for each state I practice in via telehealth?

A: Yes. You need a DEA registration in each state where you’re prescribing controlled substances to patients. Telehealth is considered to occur where the patient is located, so treating patients in three states requires three state licenses and three DEA registrations.

Q: What’s the difference between state telehealth laws and federal DEA rules?

A: Federal DEA rules set the baseline for controlled substance prescribing. State laws can be stricter (but not more lenient). For example, Florida’s law allows Schedule II telehealth prescribing only for psychiatric treatment, inpatient, hospice, or nursing home — that’s stricter than federal law. You must follow whichever is more restrictive.

Q: Can I prescribe buprenorphine for opioid use disorder via telehealth?

A: Yes, and it’s one of the most protected telehealth uses. Under proposed DEA rules, you could prescribe buprenorphine via telehealth (even audio-only) for up to 6 months before requiring an in-person visit. The X-waiver requirement was eliminated in 2023, so any DEA-registered prescriber can prescribe buprenorphine for OUD.

Q: What about audio-only (phone) visits for prescribing controlled substances?

A: Generally not acceptable for most controlled substances under current DEA guidance. The telemedicine exception requires real-time audio-visual communication (video). The exception is buprenorphine for OUD, which explicitly allows audio-only under proposed rules. For non-controlled psychiatric medications, audio-only may be acceptable depending on state law.

Q: How often do I need to check the PDMP?

A: It varies by state. New York requires checking before every Schedule II–IV prescription. California requires checking before initial prescription and every 4 months during ongoing treatment. Texas, Pennsylvania, and Illinois require checking before opioid and benzodiazepine prescriptions. Check your state’s specific PDMP requirements — most mandate it at minimum before first prescription.

Q: What documentation do I need for telehealth controlled substance prescribing?

A: Document everything you would for an in-person visit: chief complaint, history of present illness, psychiatric history, substance use history, mental status exam, diagnosis, treatment plan, informed consent for telehealth and medication, rationale for controlled substance prescription, risks/benefits discussed, and any PDMP findings. In Florida, explicitly document the psychiatric indication for Schedule II prescriptions.

Q: Can out-of-state providers prescribe controlled substances via telehealth in Florida?

A: Yes, but you need to either obtain a Florida medical license OR register as an out-of-state telehealth provider with Florida. Either way, you’re bound by Florida’s rules (Schedule II only for psychiatric treatment, etc.). The registration option is faster than full licensure but has limitations — you can’t open a physical office in Florida, for example.

References & Sources

As of February 2026

1. U.S. Department of Health and Human Services (HHS) Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026’ – January 2, 2026 – www.hhs.gov

2. U.S. Drug Enforcement Administration (DEA) Press Release – ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Care and Protect Patient Well-being’ – January 16, 2025 – www.dea.gov

3. Substance Abuse and Mental Health Services Administration (SAMHSA) – ‘Medication Access and Training Expansion (MATE) Act and Waiver Elimination’ – Updated 2023 – www.samhsa.gov

4. Florida Statutes §456.47 – ‘Use of telehealth to provide services’ – 2025 Edition – www.leg.state.fl.us

5. Akerman LLP Healthcare Law Analysis – ‘Harmonizing Federal and Florida Laws on Prescribing Controlled Substances Through Telehealth’ – March 2023 – www.akerman.com

6. Texas Medical Board – ‘Prescriptive Authority and Supervision FAQs’ – Updated 2024 – www.tmb.texas.gov

7. Tebra (formerly Kareo) – ‘State-by-State Breakdown of Nurse Practitioner Practice Authority Laws’ – Updated December 4, 2025 – www.tebra.com

8. JD Supra Legal Analysis – ‘States and Feds Signal Big Changes to Telehealth Prescribing of Controlled Substances’ – February 2023 – www.jdsupra.com

9. Texas Legislature Online – ‘Senate Bill 2527 Analysis (88th Legislature)’ – Telehealth Prescribing Provisions – 2023 – capitol.texas.gov

10. California Medical Board – Newsletter Vol. 169 (New Laws and Regulations for 2025) – Q4 2024 – www.mbc.ca.gov

This content is for informational purposes only and does not constitute legal or medical advice. Regulations are subject to change. Providers should consult their state medical board, DEA regional office, and legal counsel for specific guidance on their practice. Last updated February 2026.

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=WASHINGTON%E2%80%94JANUARY%202%2C%202026%E2%80%94The%20U,while%20permanent%20rules%20are%20finalized
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,while%20permanent%20rules%20are%20finalized
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=Expansion%20of%20Buprenorphine%20Treatment%20via,Telemedicine%20Encounter
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=For%20the%20first%20time%20online,being%20of%20patients
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=In%20developing%20these%20rules%2C%20DEA,person%20by%20the%20medical%20provider
• https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html#:~:text=telehealth%20to%20prescribe%20schedules%20III,one%20of%20the%20following%20categories
• https://www.jdsupra.com/legalnews/states-and-feds-signal-big-changes-to-9301791/#:~:text=of%20Ohio%E2%80%99s%20new%20telehealth%20prescribing,substance%20use%20disorder%20treatment%2C%20is
• https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html#:~:text=No%20special%20registration%20is%20required,the%20State%20to%20do%20so
• https://www.tebra.com/theintake/checklists-and-guides/legal-and-compliance/nurse-practitioner-laws-by-state#:~:text=,start%20their%20own%20medical%20practices